Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC. (Q37702172)
Jump to navigation
Jump to search
scientific article published on 18 June 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC. |
scientific article published on 18 June 2016 |
Statements
1 reference
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC. (English)
1 reference
Hua Zhang
1 reference
Weiran Liu
1 reference
Yuesong Yin
1 reference
Jun Wang
1 reference
Bowen Shi
1 reference
Lianmin Zhang
1 reference
Dong Qian
1 reference
Chenguang Li
1 reference
Shengguang Wang
1 reference
Jinfang Zhu
1 reference
Liuwei Gao
1 reference
Qiang Zhang
1 reference
Bin Jia
1 reference
Ligang Hao
1 reference
Changli Wang
1 reference
Bin Zhang
1 reference
1 reference
1 reference
Identifiers
1 reference